Samik Pharmaceutical Company Ltd. logo

Samik Pharmaceutical Company Ltd. (014950)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
5,610. 00
+280
+5.2533%
61.82B Market Cap
- P/E Ratio
- Div Yield
829,952 Volume
- Eps
5,330
Previous Close
Add Transaction
Day Range
5,240 5,910
Year Range
3,705 25,050
Want to track 014950 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

014950 closed today higher at ₩5,610, an increase of 5.2533% from yesterday's close, completing a monthly decrease of -14.3511% or -₩940. Over the past 12 months, 014950 stock lost -59.8712%.
014950 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

014950 Chart

Samik Pharmaceutical Company Ltd. (014950) FAQ

What is the stock price today?

The current price is ₩5,610.00.

On which exchange is it traded?

Samik Pharmaceutical Company Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 014950.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 61.82B.

Has Samik Pharmaceutical Company Ltd. ever had a stock split?

No, there has never been a stock split.

Samik Pharmaceutical Company Ltd. Profile

- Industry
- Sector
Choong-Hwan Lee CEO
KRX SM Exchange
- ISIN
South Korea Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Samik Pharmaceutical Company Ltd. is a renowned pharmaceutical manufacturer based in South Korea, with a robust specialization in the research, development, and production of both prescription and over-the-counter medications. Established in 1973, the company originally concentrated on natural medicine solutions before transitioning into the production of oral pharmaceuticals, aligning with its expansive growth strategy. The Central Research Institute, founded in 1995, exemplifies Samik’s commitment to innovation across several significant therapeutic areas. These include cardiovascular, endocrine, respiratory, gastrointestinal systems, as well as pediatric health and cold remedies. The company’s development pipeline is rich with promising new drug candidates derived from natural substances, a diverse array of generic medications, and enhanced drug formulations, showcasing its dedication to fulfilling a wide spectrum of health needs. Furthermore, Samik is acknowledged for its ability to optimize drug efficacy and safety through cutting-edge technologies such as drug repositioning and formulation control. By making continual investments in research and development, and by fostering synergies with academic institutions, Samik Pharmaceutical plays a critical role in advancing healthcare solutions in South Korea. The company remains devoted to delivering innovative, safe, and globally compliant pharmaceutical products to cater to a diverse patient population.

Products and Services

  • Prescription Medications

    Samik Pharmaceutical develops a wide range of prescription medications that cover numerous therapeutic areas. These medications are aimed at effectively treating chronic and acute health conditions, ensuring that patients receive the necessary treatment for their specific ailments.

  • Over-the-Counter Medications

    The company offers an extensive selection of over-the-counter drugs designed for self-care. These medications provide accessible solutions for common ailments such as colds, allergies, and minor pain relief, allowing consumers to manage their health with ease.

  • Research and Development

    Samik is heavily invested in research and development, continuously seeking new drug candidates, especially those derived from natural substances. This focus not only hones in on innovating new treatment options but also improves existing formulations to better meet patient needs.

  • Generics

    The company produces a variety of generic medications that provide cost-effective alternatives to brand-name drugs while maintaining high standards of quality and efficacy. These generics contribute to broader access to essential medications for patients and healthcare providers.

  • Advanced Formulation Technologies

    Utilizing advanced formulation control techniques, Samik Pharmaceutical ensures the optimization of drug delivery and absorption. This commitment to technology enhances the overall efficacy and safety of their pharmaceutical products, resulting in improved patient outcomes.

  • Collaboration with Academic Institutions

    Samik actively collaborates with academic partners to foster innovation and research in the pharmaceutical field. These partnerships facilitate knowledge exchange and contribute to the development of advanced therapies for various health challenges.

Contact Information

Address: 15th floor A Tower
Phone: 82 2 928 0661